Directory
>
Andy Scharenberg
Andy Scharenberg
Co-founder and Member, Board of Directors | MPM BioImpact
Washington, Seattle, United States
Andy Scharenberg
Summary
Andy Scharenberg is a distinguished physician, scientist, and entrepreneur based in Seattle, Washington. As the CEO of Umoja Biopharma, he is at the forefront of developing innovative therapies using CAR T-cell technology to combat cancer, particularly in pediatric patients. With a strong background in immunology and cell editing technology, Andy has held several key leadership positions, including Chief Scientific Officer at Cellectis and Casebia Therapeutics. His expertise extends to serving on the Scientific Advisory Board of bluebird bio and co-founding Generation Bio, where he plays a pivotal role in steering scientific direction. With over two decades in the industry, Andy combines his medical training with a passion for entrepreneurship, making significant contributions to the field of biopharma. His experience spans both corporate and startup environments, reflecting a versatile career dedicated to advancing healthcare solutions. Andy's work is characterized by a commitment to innovation and improving patient outcomes through cutting-edge technology.
Andy Scharenberg
Work Experience
Chief Executive Officer at
Umoja Biopharma
November 2019 - Present
Andy Scharenberg
Education
University of North Carolina School of Medicine, MD, Medicine
January 1991 - January 1993
Frequently Asked Questions about Andy Scharenberg
What is Andy Scharenberg email address?
Andy Scharenberg's primary email address is ************@generationbio.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Andy Scharenberg work for?
Andy Scharenberg is a Co-founder and Member, Board of Directors at MPM BioImpact.
Where Andy Scharenberg graduated from?
Andy Scharenberg holds a degree in null from University of North Carolina School of Medicine.
How can I directly contact Andy Scharenberg?
To contact Andy Scharenberg directly, you can use the email address ************@generationbio.com. Complete contact information is available upon registration with Muraena.
Who is Andy Scharenberg?
Andy Scharenberg is a distinguished physician, scientist, and entrepreneur based in Seattle, Washington. As the CEO of Umoja Biopharma, he is at the forefront of developing innovative therapies using CAR T-cell technology to combat cancer, particularly in pediatric patients. With a strong background in immunology and cell editing technology, Andy has held several key leadership positions, including Chief Scientific Officer at Cellectis and Casebia Therapeutics. His expertise extends to serving on the Scientific Advisory Board of bluebird bio and co-founding Generation Bio, where he plays a pivotal role in steering scientific direction. With over two decades in the industry, Andy combines his medical training with a passion for entrepreneurship, making significant contributions to the field of biopharma. His experience spans both corporate and startup environments, reflecting a versatile career dedicated to advancing healthcare solutions. Andy's work is characterized by a commitment to innovation and improving patient outcomes through cutting-edge technology.
Andy`s contact details
************@generationbio.com
******************@umoja-biopharma.com
********@u.washington.edu
************@bluebirdbio.com
******@uw.edu
******@washington.edu
************@mpmcapital.com
Colleagues
Post-Baccalaureate Research Fellow
Head of Oncology Research